RN7SK pseudogene 265 (RN7SKP265)

RN7SK pseudogene 265 is a pseudogene related to the 7SK small nuclear RNA (7SK snRNA) family[3]. Unlike the functional 7SK snRNA, which forms part of the 7SK small nuclear ribonucleoprotein complex involved in the regulation of RNA polymerase II transcriptional elongation[1][2], this pseudogene does not produce a functional RNA product and does not play a direct biological or therapeutic role. Context & Supporting Details: - Pseudogenes are genomic DNA sequences similar to normal genes but are non-functional; they typically arise from gene duplication or retrotransposition and often lack regulatory elements, resulting in no or little expression and no production of functional RNA or protein. - The canonical functional gene (not the pseudogene) for 7SK RNA is critical for regulating the activity of positive transcription elongation factor b (P-TEFb) and, in turn, RNA polymerase II-mediated transcription[1][2]. - No evidence from gene databases or the literature supports any direct functional role, drug interaction, or implication in disease for RN7SKP265 itself[3]. - Pseudogenes may sometimes be transcribed or exert regulatory effects in rare contexts, but there is no information suggesting this for RN7SKP265. - The gene is listed in genomic databases (e.g., BioGPS, NCBI Gene) without functional annotation, confirming its status as a non-target pseudogene[3]. Summary Convention Application: - This entity is a pseudogene, not a functional receptor, enzyme, or drug target. - It should not be considered a therapeutic or biological target. - No structured information (drug, disease, mechanism, etc.) applies. - The entry could be flagged as "incorrect" or "not a target" for databases of druggable targets.

Other names

RNA, 7SK small nuclear pseudogene 265RN7SKP265